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Abstract
Background: For a long time now, glucose has been thought to be the main, if not the sole substrate for brain
energy metabolism. Recent data nevertheless suggest that other molecules, such as monocarboxylates (lactate
and pyruvate mainly) could be suitable substrates. Although monocarboxylates poorly cross the blood brain
barrier (BBB), such substrates could replace glucose if produced locally.
The two key enzymatiques systems required for the production of these monocarboxylates are lactate
dehydrogenase (LDH; EC1.1.1.27) that catalyses the interconversion of lactate and pyruvate and the pyruvate
dehydrogenase complex that irreversibly funnels pyruvate towards the mitochondrial TCA and oxydative
phosphorylation.
Results: In this article, we show, with monoclonal antibodies applied to post-mortem human brain tissues, that
the typically glycolytic isoenzyme of lactate dehydrogenase (LDH-5; also called LDHA or LDHM) is selectively
present in astrocytes, and not in neurons, whereas pyruvate dehydrogenase (PDH) is mainly detected in neurons
and barely in astrocytes. At the regional level, the distribution of the LDH-5 immunoreactive astrocytes is laminar
and corresponds to regions of maximal 2-deoxyglucose uptake in the occipital cortex and hippocampus. In
hippocampus, we observed that the distribution of the oxidative enzyme PDH was enriched in the neurons of the
stratum pyramidale and stratum granulosum of CA1 through CA4, whereas the glycolytic enzyme LDH-5 was
enriched in astrocytes of the stratum moleculare, the alveus and the white matter, revealing not only cellular, but
also regional, selective distributions. The fact that LDH-5 immunoreactivity was high in astrocytes and occurred
in regions where the highest uptake of 2-deoxyglucose was observed suggests that glucose uptake followed by
lactate production may principally occur in these regions.
Conclusion: These observations reveal a metabolic segregation, not only at the cellular but also at the regional
level, that support the notion of metabolic compartmentalization between astrocytes and neurons, whereby
lactate produced by astrocytes could be oxidized by neurons.
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In 1988, Fox and Raichle observed by positron emission
tomography (PET) a mismatch between glucose uptake
and oxygen consumption, raising the possibility that aer-
obic glycolysis, i.e. the nonoxidative consumption of glu-
cose in the presence of oxygen, may occur in the brain
during focal physiologic neural activity [1,2]. Further sup-
port to this idea was brought by the observation that a lac-
tate peak could be measured during physiological
activation by 1H-magnetic resonance spectroscopy (MRS)
[3,4]. With the 2-deoxyglucose autoradiographic tech-
nique, glucose uptake has consistently been observed in
the neuropil, i.e. in regions enriched in dendrites, axons
and the astrocytic processes that ensheathe synapses, not
the cell bodies [5,6].
Since modern imaging techniques such as PET and func-
tional magnetic resonance imaging (fMRI) are being
increasingly used for clinical and fundamental biomedi-
cal research, it is of interest to understand cellular bio-
chemical events underling observed signals.
These signals have been shown to result from the interac-
tions between different cerebral cells, raising the concept
of "neurovascular unit", including neurons, astrocytes
and the vascular endothelium, whereby neuronal activity
modulates vascular tension and metabolite delivery from
the bloodstream [7]. Apparently, the key cell for the con-
trol of vascular tension is the astrocyte [8] (for review, see
[9]). For these authors, the vascular tonus is regulated via
the stimulation of astrocytic glutamate receptors
(mGluRs) triggering the release of vasoactive arachidonic
acid metabolites. However, various teams [10-13] seem to
think that the cytosolic NADH/NAD+ ratio plays a key role
in the modulation of vascular tonus. This ratio is though
to be in very close equilibrium with the pyruvate/lactate
ratio [14] that depends on glycolysis.
Since pyruvate represents the end-point of glycolysis in
mammalian cells, our goal in this study was to indirectly
investigate its fate by localizing the two major enzymatic
components of its energy production pathways, i.e. the
pyruvate dehydrogenase complex (PDHC) and lactate
dehydrogenase subunit M (LDH-5).
PDHC is a large, highly organized assembly of several dif-
ferent catalytic and regulatory subunits which catalyzes
the oxidative decarboxylation of pyruvate to form acetyl-
CoA, CO2 and NADH. Pyruvate dehydrogenase (PDH)
catalyzes the irreversible entry of pyruvate into the tricar-
boxylic acid cycle and is therefore a marker for oxidative
metabolism, whereas lactate dehydrogenase M subunit
(LDH-5 subunit) is necessary for glycolysis to occur at
high rate with production of lactate [15,16]. Using immu-
nohistochemistry, we seeked to examine their distribution
in the human primary visual cortex and hippocampus. In
these two regions, 2-deoxyglucose has been shown to
accumulate in specific layers, i.e. the hippocampal stra-
tum moleculare [6] and the layer IV of area 17 [17].
Results
Specificity of the antibodies
Immunohistochemical and Western blot controls clearly
showed that monoclonal antibodies (mAbs) against
LDH-5 and PDH were specific for lactate dehydrogenase
isoenzyme 5 and pyruvate dehydrogenase, respectively
(fig 1). Figure 1A illustrates the Western Blot characteriza-
tion of the anti-LDH-5 monoclonal antibody. In all cases,
the antibody was specific for the monomeric form of the
LDH-5 subunit whose molecular weight is 35 kDa. The
antibody did not react with purified LDH-1 (fig 1A, 3),
confirming its specificity for the M subunit of the enzyme.
It reacted faintly with rabbit heart extracts (fig 1A, 1) that
contain minute amounts of the LDH-5 subunit, and
strongly with rabbit muscle extracts (fig 1A, 2), human
hippocampal extracts (fig 1A, 4) and the immunogen
(purified LDH-5 extracted from rabbit muscle, not
shown).
Figure 1B illustrates the Western blot characterization of
the mAb against PDH. On human hippocampal extracts,
the antibody exclusively stained a band of approximately
43 kDa that is located in the mitochondrial fraction (fig
1B, 2) and failed to label the cytosolic fraction (fig 1B, 3).
The same applied to the human occipital cortex (fig 1B, 4–
6). The antibody stained a 43-kDa band from pyruvate
dehydrogenase purified from porcine heart (fig 1B, 7) and
did not stain purified LDH-5 extracted from rabbit muscle
(fig 1B, 8, not shown as out of range of figure). Overall,
the immunoreactivity at 43 kDa in human mitochondrial
extracts strongly suggests that the monoclonal antibody
recognizes the E1α subunit of human PDHC.
Biochemical characterization of anti-LDH-5 (A) and anti-PDH (B) monoclonal antibodies by SDS-PAGEF gur  1
Biochemical characterization of anti-LDH-5 (A) and anti-
PDH (B) monoclonal antibodies by SDS-PAGE. 1A) 1, rabbit 
heart; 2, rabbit muscle; 3, human LDH-1 and 4, human hip-
pocampal extracts. 1B) 1–3, human hippocampal extracts (2, 
mitochondrial fraction, 3, cytosolic fraction), 4–6, human 
occipital cortex extracts(5, mitochondrial fraction, 6, 
cytosolic fraction), 7, PDH from porcine heart and 8, LDH-5 
from rabbit muscle (absence of positive band at 35 kDa omit-
ted).Page 2 of 6
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The characterized monoclonal antibodies revealed pat-
terns of immunostaining that were constant in all human
brains investigated (figs. 2, 3). The two antibodies raised
against two different subunits of the PDHC gave identical
results.
Human occipital cortex
In the human occipital cortex, area 17 was more specifi-
cally studied (figure 2). The PDH immunoreactivity was
principally observed in layer IV, staining neuronal cell
bodies (fig 2A, C). At the cellular level, virtually all neuro-
nal bodies and dendrites were stained, whereas astrocytes
were very faintly stained.
Using polyclonal antibodies (pAbs), we have previously
shown that the LDH immunoreactivity of both M and H
subunits is enriched in layers IV and VI of the occipital
area 17 [15]. Here, as shown in figure 2B and 2D, we con-
firm with a monoclonal antibody our previous observa-
tion of the apparently exclusive cellular distribution of
LDH-5 immunoreactivity in astrocytes throughout the
white matter and in cortical layer I of the visual cortex
[15]. In addition, protoplasmic astrocytes also appear in
layer IV of area 17 (fig 2E) in close association with den-
drites, providing a laminar staining similar to that
observed by cytochrome oxidase histochemistry, immu-
nohistochemistry and also by 2-deoxyglucose uptake
studies [18,19]. In the white matter of the occipital cortex,
but also in that of parietal and frontal cortices virtually all
astrocytes were intensively LDH-5 immunoreactive, sug-
PDH like (A, C) and LDH-5 like (B, D) immunoreactivity in the human hippocampus at low (A, B) and high (C, D) magni-ficationFigure 3
PDH like (A, C) and LDH-5 like (B, D) immunoreactivity in 
the human hippocampus at low (A, B) and high (C, D) magni-
fication. Microphotograph E shows double immunolabeling 
(PDH, granular neuron, blue, ; LDH-5, protoplastmic astro-
cyte, brown, *). Scale A, B; 500 µm; C, D: 25 µm and E: 20 
µm. Abbreviations SP: stratumpyramidale, SM: stratum 
moleculare and SG: stratum granulosum. Scale (A), B; 500 
µm; (C), D: 25 µm and E: 20 µm.
PDH like (A, C) and LDH-5 like (B, D) immunoreactivity in area 17 of the human occipital cortex at low (A, B) and h gh (C, D) magnificationFigure 2
PDH like (A, C) and LDH-5 like (B, D) immunoreactivity in 
area 17 of the human occipital cortex at low (A, B) and high 
(C, D) magnification. Clear astrocytic arborescence can be 
seen in plate D. Microphotograph E shows at high magnifica-
tion a PDH immunoreactive neuron (a typical pyramidal neu-
ron of cortical layer V, blue, ) of layer V and a LDH-5 
immunoreactive astrocyte (protoplasmic astrocyte, brown, 
*) in layer IV close to the dendrite of the pyramidal neuron. 
Scale A, B; 500 µm; C, D: 25 µm and E: 20 µm.Page 3 of 6
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principally glycolytic.
Human hippocampus
Figure 3 shows the immunoreactivity of PDH (3A, 3C)
and LDH-5 (3B, 3D) antibodies in the human hippocam-
pus. It can clearly be observed a complementary staining
of both antibodies, with intense immunostaining of LDH-
5 in CA4, stratum moleculare and alveus while the stra-
tum granulosum and the CA layers show no staining (fig
3B and 3C). PDH immunoreactivity is virtually present
only in the stratum granulosum and the CA1-3 layers.
Note the cellular, but also the regional metabolic com-
partmentalization of the two enzymes. The PDH immu-
nolabeling was very similar to the labelling due to the pAb
against LDH-1 that we have previously produced and
characterized [15].
For both regions studied, a faint PDH immunoreactivity
was revealed in astrocytes following longer incubation
with the primary antibodies. In spite of signal amplifica-
tion with TSA, no additional immunoreactivity was
detected (data not shown).
Discussion
In this article, we describe for the first time the immuno-
histochemical distribution of PDH and LDH-5 subunits
in two regions of the human brain. Our monoclonal anti-
body to LDH-5 is highly specific that subunit of the
enzyme and further confirms the results reported previ-
ously with the polyclonal antibody raised against rabbit
muscle LDH-5 [15]. However, very recently, O'Brien et al.
[20] report that in isolated rat brain synaptosols and cyto-
plasms of primary cultured neurons and astrocytes that
the LDH-5 isoform (i.e. the M subunit of LDH) is present
also in neurons, findings that seem to be in contradiction
with the data presented here. Of course however, cell cul-
tures do not always reflect in vivo nerve cell phenotypes. In
the human occipital cortex and hippocampus, the 2-DG
autoradiographic technique has shown that glucose is
principally taken up in specific layers, i.e. the layer IV of
the occipital cortex [17] and the stratum moleculare of the
hippocampal formation [6]. In layer IV of the occipital
cortex, a cellular compartmentalization was observed
between LDH-5 and PDH immunolabeling, suggesting
that astrocytes might principally produce lactate at a high
rate and that the transformation of pyruvate to acetyl CoA
might essentially occur in neurons. In the hippocampus,
the same cellular segregation was observed, with the addi-
tional observation of a regional mismatch between both
enzymes. Since 2-DG has clearly been observed to be
taken up in the stratum moleculare [6], a layer enriched in
LDH-5 immunoreactive astrocytes, this finding is consist-
ent with the existence of a high glycolytic activity in astro-
cytes resulting in lactate production [21].
LDH-5 immunoreactivity was exclusively visualized in
astrocytes in agreement with previous observation in
human [15] and in astroglial cell cultures [22]. No neu-
rons revealed any LDH-5 immunoreactivity. The LDH-5
immunoreactive astrocytes were found in regions where
2-DG uptake is known to be maximal. However, LDH-5
immunoreactive astrocytes were also present in regions
where no particular 2-DG uptake has been detected, i.e.
the first cortical layer of occipital area 17, the hippocam-
pal alveus and the white matter. It is worth noting that
these areas are virtually devoid of neuronal profiles.
Throughout the white matter, LDH-5 labelled astrocytes
were numerous, and their distribution was homogenous.
In the living rat, the uptake of 2-deoxyglucose has been
found to be higher in grey matter than in white matter by
a factor of approximately three-fold [23], whereas cyto-
chrome oxidase activity is about eight- to twelve-fold
higher in grey matter than in white matter [24]. These
observations suggest that the white matter might rely
more on glycolytic metabolism than on oxidative phos-
phorylation and therefore produce lactate through LDH-5
subunit activity. Indeed, there is very little PDH immuno-
reactivity in the white matter, while the LDH-5 immu-
nolabeling is abundant and restricted to astrocytes.
Overall, the localization of the PDH immunoreactivity
was similar to that previously observed [25,26] and also
overlapped previous reports of cytochrome oxidase
immunolabeling, although patches were not observed
[18].
Conclusion
Results reported in this article demonstrate the existence
of a cellular and regional compartmentalization in two
enzymes (LDH-5 and PDH) involved in glucose metabo-
lism. At the cellular level, this compartmentalization is
consistent with the notion of the existence of metabolic
coupling between neurons and astrocytes, also known as
the astrocyte neuron lactate shuttle hypothesis (ANLS).
Although the existence of the ANLS is still debated
[27,28], evidence has come from two-photon microscopy.
Kasischke et al. [29] measured, at a cellular resolution, the
variations of fluorescence due to the variation of the free
NADH/NAD+ ratio. Their results shown that neuronal
activity provokes oxidative metabolism in neurons closely
followed by glycolytic metabolism in neighbouring astro-
cytes. Our present observations are fully consistent with
this ex vivo data, whereby the intital oxidative metabolism
is initiated by PDH catalysis and has a neuronal localiza-
tion. The later the glycolytic activity is catalyzed by LDH-
5 and is expressed in astrocytes. This late astrocytic glyco-
lytic metabolism could be glutamate uptake stimulated
[30]. As mentioned previously variation in NADH/NAD+
in astrocytes may also be a key event modulating vascular
tension [11]. If this is the case, one step forward has beenPage 4 of 6
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nals emitted in modern imaging techniques.
In conclusion, describing not only the cellular but also the
regional distribution of the typically glycolytic enzyme
LDH-5 in comparison to the oxidative PDH distribution
provides new insight to the highly metabolic coupling of
the interactions between brain cells.
Methods
Preparation of tissues
All experimental procedures were approved by the ethics
comity of the Geneva School of Medicine (Protocol n° 04-
187/Psy 04-023). The brains of 10 control patients (4
females, 6 males, mean age 72 +/- 4, post-mortem delay <
12 h) with no history of neurological, metabolic or psy-
chiatric disorder and without histopathological lesions
were obtained at autopsy from the Hospitals of the Uni-
versity of Geneva School of Medicine. The brains were
routinely screened for histopathological lesions, using
classic histological stains and immunohistochemistry
procedures as described in detail elsewhere [31]. Some
blocks of the hippocampal formation and occipital cortex
were immediately frozen with CO2 for biochemical anal-
yses, while others were fixed with 4% paraformaldehyde
in 0.1 M PBS for 18 hours, then immersed in a solution
containing 5% sucrose for 48 hours, and in 10% sucrose
for another 48 hours before being stored at -80°C for less
than a year.
Antibodies
Wistar male rats (IFFA CREDO, Les Oncins, France) were
immunised by multiple injections of LDH-5 purified from
rabbit muscle (SIGMA, Buchs, Switzerland. Hybridomas
were produced by fusion of splenocytes with log-phase
Sp2 myeloma cells in the presence of polyethylene glycol
(MW 4000; Merck, Switzerland) according to the method
reported by Lövenborg [32] and described in detail else-
where [33]. After screening by immunohistochemistry
and western Blot (see below) for hybridomas producing
monoclonal antibodies (mAbs) against LDH-5, positive
hybridomas were propagated in a Biofarm 2000 system
(Digitana, Switzerland).
The mouse mAbs respectively against the E1α and E2 sub-
units of human pyruvate dehydrogenase were purchased
from Molecular Probes, Inc. Oregon, USA.
Western blot analysis
The mAb against LDH-5 was characterized by immuno-
dot, immunohistochemistry on rabbit muscle and heart
sections, and by western blot analysis as described previ-
ously [15]. "Sodium-Dodecyl-Sulphate polyacrylamide
gel electrophoresis" (SDS-PAGE) was performed accord-
ing to the method of Laemmli [34]. Fresh tissue extracts
from human hippocampus (CA) and occipital cortex
(CO) were homogenized on ice with diluted sample
buffer. Purified proteins were all from Sigma, Switzerland
and were also diluted in sample buffer. For the mAb
against PDH characterization, mitochondrial fractions
and cytosolic fractions of CA and CO were extracted by
successive centrifugations in 0.01 M Tris-HCl with 0.32 M
sucrose according to Hamberger et al. [35]. Samples were
heated at 100°C for 5 min, and approximately 50 µg of
protein were loaded onto the gels. The extracts were then
electrophoresed on polyacrylamide gels (12%) and trans-
ferred electrophoretically onto nitrocellulose membranes
(Bio-Rad, Glattbrugg, Switzerland). After being blocked
with non-fat dry milk and washed in phosphate buffer
saline (PBS, pH 7.4), the membranes were incubated
overnight with the antibodies. Detection of the bound
antibodies was performed as described under "Immuno-
histochemistry" and/or using ECL+ with subsequent
exposure to Hyperfilms (Amersham, Switzerland).
Molecular weight markers were used in all gels (Kaleido-
scope and Low Range Prestained Standards from Bio-
Rad).
Immunohistochemistry
For simple immunohistochemical labelling, adjacent 20
µm cryostat (Microm HM550) cut brain sections were
mounted on 0.01% poly-L-lysine (PLL, Fluka, Switzer-
land) coated slides and incubated overnight at 4°C in PBS
containing 3% bovine serum albumin (BSA, Sigma) and
0.3% Triton X with either the anti-LDH-5 supernatant
diluted 1/500 or the anti-PDHE1α diluted 1/1000 (1/
10000 for the anti-PDHE2) according to the manufactur-
ers instructions. Following incubation, sections were
rinsed in PBS and incubated for one hour at room temper-
ature with horseradish peroxidase conjugated polyclonal
rabbit anti-rat IgG (for LDH-5) or anti mouse IgG (for
PDHE1α and PDHE2) (DAKO, Switzerland) diluted 1/
100 in PBS containing 3% BSA and 0.3% Triton X. Follow-
ing PBS washes, immunoreactions were revealed for 20
min at room temperature in PBS containing 0.02% 3,3'-
diaminobenzidine (DAB, Sigma) and 0.002% H2O2.
For another series of simple and double labelling, 40 µm
cryostat cut free floating sections were treated as above
with the difference that the PDHE1α immunolabeling
was revealed in 50 mM Tris-HCl containing 0.02% DAB
and 0.002% H2O2 with 0.1% nickel ammonium sulphate
[36]. Double labelling was sequential, i.e. PDHE1α
immunoreactivity was revealed before processing to LDH-
5 immunolabelling.
An additional subset of sections were incubated for 48
hours in the two anti-PDH antibodies and processed as
above or subjected to the Tyramide Signal AmplificationPage 5 of 6
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USA) according to the manufacturer's instructions.
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